These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 23474633

  • 1. PET/CT imaging in neuroblastoma.
    Piccardo A, Lopci E, Conte M, Foppiani L, Garaventa A, Cabria M, Villavecchia G, Fanti S, Cistaro A.
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):29-39. PubMed ID: 23474633
    [Abstract] [Full Text] [Related]

  • 2. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND, Gaze MN, Sullivan K, Aldridge M, Waddington W, Almuhaideb A, Bomanji JB.
    J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
    [Abstract] [Full Text] [Related]

  • 3. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
    Kushner BH, Yeung HW, Larson SM, Kramer K, Cheung NK.
    J Clin Oncol; 2001 Jul 15; 19(14):3397-405. PubMed ID: 11454888
    [Abstract] [Full Text] [Related]

  • 4. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
    Kroiss A, Putzer D, Uprimny C, Decristoforo C, Gabriel M, Santner W, Kranewitter C, Warwitz B, Waitz D, Kendler D, Virgolini IJ.
    Eur J Nucl Med Mol Imaging; 2011 May 15; 38(5):865-73. PubMed ID: 21279352
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Dhull VS, Sharma P, Patel C, Kundu P, Agarwala S, Bakhshi S, Bhatnagar V, Bal C, Kumar R.
    Nucl Med Commun; 2015 Oct 15; 36(10):1007-13. PubMed ID: 26049371
    [Abstract] [Full Text] [Related]

  • 6. 124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.
    Cistaro A, Quartuccio N, Caobelli F, Piccardo A, Paratore R, Coppolino P, Sperandeo A, Arnone G, Ficola U.
    Nucl Med Rev Cent East Eur; 2015 Oct 15; 18(2):102-6. PubMed ID: 26315872
    [Abstract] [Full Text] [Related]

  • 7. Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.
    Piccardo A, Lopci E, Conte M, Garaventa A, Foppiani L, Altrinetti V, Nanni C, Bianchi P, Cistaro A, Sorrentino S, Cabria M, Pession A, Puntoni M, Villavecchia G, Fanti S.
    Eur J Nucl Med Mol Imaging; 2012 Jan 15; 39(1):57-71. PubMed ID: 21932116
    [Abstract] [Full Text] [Related]

  • 8. Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.
    Xia J, Zhang H, Hu Q, Liu SY, Zhang LQ, Zhang A, Zhang XL, Wang YQ, Liu AG.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct 15; 37(5):649-660. PubMed ID: 29058276
    [Abstract] [Full Text] [Related]

  • 9. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
    Franzius C, Hermann K, Weckesser M, Kopka K, Juergens KU, Vormoor J, Schober O.
    J Nucl Med; 2006 Oct 15; 47(10):1635-42. PubMed ID: 17015899
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
    Piccardo A, Puntoni M, Lopci E, Conte M, Foppiani L, Sorrentino S, Morana G, Naseri M, Cistaro A, Villavecchia G, Fanti S, Garaventa A.
    Eur J Nucl Med Mol Imaging; 2014 Jun 15; 41(6):1046-56. PubMed ID: 24562643
    [Abstract] [Full Text] [Related]

  • 11. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
    Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK.
    J Clin Oncol; 2009 Nov 10; 27(32):5343-9. PubMed ID: 19805691
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
    Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A.
    Nucl Med Commun; 2011 Jul 10; 32(7):575-82. PubMed ID: 21471850
    [Abstract] [Full Text] [Related]

  • 13. Functional-metabolic imaging of neuroblastoma.
    Sharp SE, Parisi MT, Gelfand MJ, Yanik GA, Shulkin BL.
    Q J Nucl Med Mol Imaging; 2013 Mar 10; 57(1):6-20. PubMed ID: 23474631
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.
    Piccardo A, Treglia G, Fiz F, Bar-Sever Z, Bottoni G, Biassoni L, Borgwardt L, de Keizer B, Jehanno N, Lopci E, Kurch L, Massollo M, Nadel H, Roca Bielsa I, Shulkin B, Vali R, De Palma D, Cecchin D, Santos AI, Zucchetta P.
    Eur J Nucl Med Mol Imaging; 2024 Feb 10; 51(3):756-767. PubMed ID: 37962616
    [Abstract] [Full Text] [Related]

  • 18. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
    Boubaker A, Bischof Delaloye A.
    Q J Nucl Med; 2003 Mar 10; 47(1):31-40. PubMed ID: 12714952
    [Abstract] [Full Text] [Related]

  • 19. Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
    Mc Dowell H, Losty P, Barnes N, Kokai G.
    Pediatr Blood Cancer; 2009 Apr 10; 52(4):552. PubMed ID: 19058210
    [No Abstract] [Full Text] [Related]

  • 20. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
    Admiraal WM, Holleman F, Bahler L, Soeters MR, Hoekstra JB, Verberne HJ.
    J Nucl Med; 2013 Feb 10; 54(2):208-12. PubMed ID: 23318291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.